Contact Us

Have questions? 

Please email us at casl@hepatology.ca or call us at 780-436-0983 ext.234

         

123 Street Avenue, City Town, 99999

(123) 555-6789

email@address.com

 

You can set your address, phone number, email and site description in the settings tab.
Link to read me page with more information.

New Page

2019 PROGRAM

The 2019 Canadian Liver Meeting offers participants with a forum for presentation and discussion of basic science, translational and clinical aspects of liver disease. This is the 2nd year that delegates will receive the opportunity to exchange ideas, promote collaboration and foster knowledge translation among Canadian researchers, healthcare practitioners and community-based groups with interest in Hepatology. 

The program features Canadian and international speakers, the latest research presentations, state of the art symposia, and a wealth of networking opportunities with peers, trainees, allied health practitioners, and industry.

Please note: the session titles and objectives are subject to change.

Friday Saturday Sunday


Sunday, May 26

7:00 - 8:00 AM

CASL Special Interest Group Meetings

  • HBV

  • Autoimmune Liver Disease (CaNAL)

  • Transplant

  • CPHRG

  • Portal Hypertension/Complications of Cirrhosis

  • CanNASH

8:00 - 8:50 am

General Hep Paper Session

  • Abstract 47: Vitamin E is an effective treatment for NASH in people living with HIV: The CTN-PT 024 Trial

  • Abstract 159: Why Women Develop Less Hepatocellular Carcinoma: The Centrality of ESR1 and the Estrogen Effect

  • Abstract 171: CD8+ T-cell dysfunction in a murine model of liver fibrosis

  • Abstract 132: Implementation of a primary care shear-wave elastography (SWE)-based pathway to identify non-alcoholic fatty liver disease (NAFLD) patients with advanced fibrosis in a large North American urban population

  • Abstract 155: Acyl CoA Thioesterase 1 Promotes Transition from Steatosis to Non-alcoholic Steatohepatitis

9:00 - 10:15 AM

Concurrent Session

 

Immune Control/Dysfunction and Liver Disease

  • Visualizing the immune response in healthy and fatty liver in live mice
    Dr. Craig Jenne, University of Calgary

  • Mechanisms linking the hemostatic system to pro-repair macrophage activation in acute liver injury
    Jim Luyendyke, Michigan State University

  • Novel HBV tests/diagnostics
    Dr. Carla Osiowy, Public Health Agency of Canada

  • Progression towards a Functional Cure for Hepatitis B
    Norah Terrault, University of California San Francisco

End Stage Liver Disease and Liver Transplantation

  • Referral and optimizing pre-transplant (especially in NASH/NAFLD)
    Dr. Giada Sebastini, MD McGill University

  • Use of HCV + organ in transplant patients (Kidney and Liver)
    Dr. Jordan Feld, University Health Network

  • Sex and gender differences in listing and allocation for liver transplant
    Dr. Mamatha Bhat, University Health Network

10:15 - 10:45 AM

Break & Posters

10:45 - 12:00 Pm

Gold Medal Lecture & CASL Award Ceremony

Updates on the Treatments of Ascites and Hepatorenal Syndrome
Dr. Florence Wong, University of Toronto

CASL Awards and Conference Close